Background: Staphylococcus aureus is both a major pathogen and a commensal bacterium in 23 humans. It is able to adhere at the surface of epithelial cells of the anterior nares and can trigger 24 its internalization inside these non-professional phagocytic cells. To better understand the 25 interactions of clinical isolates with keratinocytes in the anterior nares, we developed and 26 validated a one-step protocol expressing enhanced green fluorescent protein (EGFP) in S. 27 aureus clinical strains with the aim to study adhesion to and internalization into mammalian 28
INTRODUCTION 45 46
Staphylococcus aureus acts as both a leading cause of infections and a commensal bacterium 47 in humans [1, 2] . Approximately one third of the worldwide population is colonized by S. 48 aureus; the anterior nares are considered as the main reservoir [1] . For long considered as an 49 exclusive extracellular bacterium, S. aureus has been shown to be able to invade many non-50 professional phagocytic cells (NPPCs) in vitro but also in vivo during colonization or infection 51 [3] [4] [5] [6] . The tripartite interaction between fibronectin, the 51 integrin exposed at the host cell 52 plasma membrane and fibronectin-binding proteins expressed by S. aureus is widely 53 acknowledged as the main internalization pathway of S. aureus in NPPCs [7] . However, several 54 others S. aureus virulence factors such as staphylococcal autolysin (Atl) and extracellular 55 adherence protein (EAP) have been found to foster S. aureus internalization in NPPCs [8, 9] . 56 By contrast to the important knowledge generated from "laboratory" strains such as Newman 57 or the 8325-4 derivative strains, little is known about the mechanisms driving the internalization 58 rate and the intracellular persistence of S. aureus clinical isolates. Up to now, genetic 59 manipulations in the Staphylococcus species relied on labour intensive protocols and only a 60 limited number of S. aureus laboratory strains have been genetically modified successfully [10] . 61
In fact, wild type S. aureus strains have an impenetrable restriction barrier preventing the uptake 62 of "foreign" DNA. Monk et al. demonstrated that DNA plasmid isolated from E. coli DH10B 63
Δdcm (called DC10B) bypasses the conserved type IV restriction system SauSI, which 64 specifically recognizes cytosine methylated DNA, enabling transformation of S. aureus clinical 65 strains [11] . This major finding has extended the possibility of genetic manipulations in S. 66 aureus especially regarding clinical strains that are protected from foreign DNA. 67
In vitro cell models associated with fluorescent labelling are valuable tools to study the 68 molecular mechanisms involved in host-pathogen interactions. However, after labelling live bacteria with fluorescent reporter, the fluorescence intensity decreases during time according 70 to the multiplication of live bacteria (i.e. the quantity of fluorescent reporter is divided by two 71 at each bacterial multiplication). The transformation of bacterial strains bearing a gene coding 72 for a fluorescent reporter such as enhanced green fluorescent protein (EGFP) helps to overcome 73 this limitation [12] and such bacteria could be tracked inside the cells for a few hours [13] . 74
The aim of the present work was to develop and validate a one-step transformation protocol for 75 constructing EGFP-expressing S. aureus clinical strains belonging to different genetic 76 backgrounds without interfering with their adhesion and internalization capacities on a 77 keratinocyte model. 78
79

MATERIALS AND METHODS 80 81
Microbiology procedures 82
The bacterial strains used in this study are listed in Table 1 . E. coli (NM522 and DC10B) 83 bacteria were grown in Luria-Bertani broth (LB) (ThermoFisher Scientific). S. aureus strains 84 were growth in brain heart infusion (BHI) (Becton Dickinson) or onto tryptic soy agar (TSA) 85 (Becton Dickinson). Culture media were incubated at 37°C with shaking at 250 rpm in case of 86 liquid medium. When required, spectinomycin (S4014, Sigma-Aldrich) was added to the 87 culture medium at the concentration of 120 and 125 mg/l for S. aureus and E. coli, respectively. 88
Antimicrobial susceptibility testing of S. aureus clinical strains was done with the Vitek2 89 system (AST-P559, bioMérieux). The minimal inhibitory concentration (MIC) to 90 spectinomycin was determined by using E-test (529240, bioMérieux). S. aureus strains were 91 genotyped using spa-typing and DNA microarray (S. aureus genotyping kit v2.0, Alere) as 92 previously described [14] . 93
EGFP-encoding plasmid preparation 95
The pBSU101 plasmid that was kindly provided by Barbara Spellerberg was used to express 96 EGFP in S. aureus. This shuttle plasmid harbours a copy of the egfp gene under the control of 97 the promoter of the CAMP-factor gene (cfb) of Streptococcus agalactiae, which enables a high-98 level EGFP expression in several Gram-positive bacteria including S. aureus [12] . The 99 pBSU101 was isolated from E. coli NM522 (laboratory collection) using mini spin columns 100 (Nucleospin 740588, Macherey Nagel) according to the manufacturer's instructions and 101 transformed into E. coli DC10B, a gift from Ian Monk, by thermal shock as described [11] . 102 103 One-step transformation protocol 104 S. aureus clinical strains were inoculated in tryptic soy broth (TSB) for 24h. Overnight culture 105 of each strain was diluted to a 0.1 optical density (OD) at 600 nm in pre-warmed TSB and 106 incubated at 37°C with 250 rpm shaking until OD reached 0.5. Cultures were transferred to 107 centrifuge tubes and chilled on ice for 10 minutes. The cells were harvested by centrifuging at 108 4500g at 4°C for 20 minutes, washed twice in ice-cold sterile water (v/v) and pelleted at 4°C. 109
The cells were then washed in 1/10, 1/25 and 1/200 volume of ice-cold 10% sterile glycerol. 110
Aliquots of 70 μl were stored at -80°C. For electroporation, the cells were thawed at room 111 temperature for 10 min, centrifuged at 5000g for 3 min and re-suspended in 50 μl of sterile 10% 112 glycerol with 500 mM sucrose. Plasmid DNA (1 μg) of pBSU101 isolated from E. coli DC10B 113 was added to the cells in a sterile 0.1 cm electroporation cuvette. The cells were pulsed once at 114 1.8 kV and 2.5 msec time constant (MicroPulser, Biorad), outgrown in 1 ml of TSB containing 115 500 mM sucrose for 90 min at 37°C, spread on TSA plates containing 120 mg/l spectinomycin 116 and incubated overnight at 37°C. 117
118
FACS analysis of EGFP-expressing S. aureus clinical strains
Fluorescence stability was checked for all the transformed strains by analyzing the fluorescence 120 means and the total fluorescent populations during the exponential phase of growth (4 hours) 121 in BHI (Becton Dickinson) in presence of spectinomycin. A 10 µl-volume of the bacterial 122 suspension was diluted in 490 µl of sterile distilled water and assayed by flow analysis cell 123 sorting (FACS) (FACSCantoII, Becton Dickinson). Relative fluorescence values were 124 determined by analyzing 50000 events for each sample using FACSDiva software (V 6.1.2, 125
Becton Dickinson). 126 127
Adhesion and internalization assays 128
Adhesion and internalization of S. aureus strains were studied in a model of HaCaT cells (Cell 129 line service) that mimics nasal colonization as described previously (Rigaill 2018). Briefly 130
HaCaT cells were seeded into 24-well plates at 1.5 x 10 5 cells per well and maintained with 131 serum-free medium constituted of 50% RPMI-1640 (R7388, Sigma-Aldrich) and 50% DMEM 132 (D6429, Sigma-Aldrich) supplemented with 2% Ultroser G (Pall), 1 mM L-Glutamine (G7513,  133 Sigma-Aldrich), 1x MEM non-essential amino acids (M7145, Sigma-Aldrich) and 1x 134 antibiotic/antimycotic solution (A5955, Sigma-Aldrich) for three days at 37°C under 5% CO2. 135 Cells were washed with PBS (806552, Sigma-Aldrich) and the medium was changed with fresh 136 RPMI-1640 (R8755, Sigma-Aldrich) 24h prior to S. aureus inoculation. Spectinomycin (240 137 mg/l) was added to the wells designed to be infected with EGFP-expressing strains. Confluent 138 cells (10 6 cells/well) were inoculated with S. aureus strains in exponential phase of growth with 139 a multiplicity of infection (MOI) of 1, and incubated for 2 hours at 37°C under 5% CO2. To 140 quantify both adhered and internalized bacteria, cells were washed 3 times with PBS to remove 141 free bacteria. To quantify only intracellular bacteria, the remaining extracellular bacteria were 142 killed by adding 10 mg/l lysostaphin (Ambi Products LLC, NY, USA) for 1h at 37°C under 5% 143 CO2. The efficacy of the lysostaphin treatment was systematically tested by plating the cell 144 supernatant. The infected HaCaT cells were finally lysed by osmotic shock using sterile water, 145 trypsin-EDTA (Sigma-Aldrich) and 1% Triton X-100 (Sigma-Aldrich) (2:1:1). The count of 146 viable bacteria was carried out by plating serial dilutions of the lysates on blood agar (43041, 147 bioMérieux) using an automatic seeder (EasySpiral Dilute, Interscience). The calculation of the 148 bacterial loads was performed after incubation at 37°C for 24 h, using a plate-reader (Scan1200, 149
Interscience). 150 151
Confocal laser scanning microscopy (CLSM) 152
HaCaT cells were grown on glass-bottom 4-chamber culture slides (C354104, Falcon). 153
Internalization assay was conducted as described above. After treatment with lysostaphin, cells 154 were washed three times with PBS and fixed with 4% paraformaldehyde (Sigma-Aldrich). Cells 155 were then permeabilized with 0.1% Triton X-100 and stained with TO-PRO-3 (T3605, Thermo 156 CC30, CC45 and CC398) were randomly selected for evaluating the transformation protocol. 172
All the strains were susceptible to spectinomycin with MIC ranging from 16 to 48 mg/l (Table  173 1). Regardless of the genetic background or the clinical origin, all the S. aureus clinical strains 174 and the reference strain ATCC 29213 were successfully transformed by electroporation with 175 pBSU101. A single colony of each EGFP-expressing S. aureus strain was phenotypically 176 selected on selective agar under UV light. The expression of EGFP was confirmed on selective 177 agar plate under UV light and by CLSM (Figure 1) . The constructs were all resistant to 178 spectinomycin with a MIC of more than 128 mg/l (data not shown). The mean proportion of EGFP-expressing transformed bacteria was 97.2% (± 2.1) for the 20 184 clinical strains (Figure 2b) . Regarding the clonal complex, the mean proportions of EGFP-185 expressing bacteria (± SD) was 97.9% (± 0.7), 97.9% (± 0.4), 96.8% (± 3.0), 98.0% (± 1.2) and 186 95.3% (± 3.0) for CC5, CC8, CC30, CC45 and CC398 strains, respectively. The mean 187 fluorescence intensity (MFI) varied from one strain to another independently of its clonal 188 complex or clinical origin (Figure 2b) . 189 190
Adhesion and internalization of EGFP-expressing S. aureus strains 191
The adhesion and internalization levels of both EGFP-expressing and WT strains were assessed 192 using a cell model of HaCaT keratinocytes inoculated at a MOI of 1. The mean ± SEM adhesion 193 level was 6.50 ± 0.06 and 6.44 ± 0.05 log CFU/10 6 cells for EGFP-expressing S. aureus and parental WT strains, respectively (Figure 3a) . The mean ± SEM internalization level at 2h post-195 inoculation was 4.04 ± 0.08 and 4.03 ± 0.07 log CFU/10 6 cells for EGFP-expressing S. aureus 196 and parental WT strains, respectively (Figure 3b) . CLSM was used to visualize EGFP-197 expressing strains inside HaCaT keratinocytes 2h post-inoculation: similar patterns of 198 intracellular bacteria were observed with all the tested strains (Figure 4) . we demonstrate that the expression of EGFP decreases neither the adhesion of transformed S. 208 aureus to keratinocytes nor their internalization into these cells. 209
The pBSU101 plasmid used in this study harbours a copy of the green fluorescent variant gene 210 egfp under the control of the CAMP-factor gene (cfb) promoter of Streptococcus agalactiae 211
[12]. By using this plasmid, the fluorescent reporter is not present at the surface of the bacteria, 212 which avoids masking S. aureus surface proteins that could be involved in adhesion or 213 internalization process. This labelling process is therefore interesting for studying interactions 214 between S. aureus and host cells. By contrast, fluorescent labelling methods using dye (e.g. 215
Vancomycin Bodipy FL) or antibodies that interact with the bacterial cell wall could modify 216
interactions with cell host receptors [15] . In this study, we show that EGFP expressed inside 217 the bacteria does not modify adhesion and internalization capacities of S. aureus. Thus we could 218 hypothesize that the expression of the fibronectin binding proteins, the major invasion factor in 219 S. aureus, is not impacted by the labelling process. 220
In addition, the EGFP expression enables live imaging of S. aureus clinical isolates because the 221 EGFP expression driven by pBSU101 does not alter the bacterial viability [12] whereas 222 vancomycin-based labelling has been found to exhibit a bacteriostatic activity that limits its use 223 However, the use of pBSU101 for transforming clinical isolates of S. aureus has some limits. 235
The EGFP fluorescence emission is known to be optimal at pH 7 but decreases almost to zero 236 at pH 5 [17]. Since internalized S. aureus can be found inside phagolysosomes, the detection of 237 these cocci can therefore be impaired. Other fluorescent proteins (e.g. red fluorescent protein) 238 have been found to resist to pH reduction and could be useful to overcome this limitation. 239
Besides, EGFP-encoding pBSU101 requires antibiotic selection to foster the transcription of 240 both acetyltransferase and EGFP. Although the use of an antimicrobial agent is easy in cell 241 models, it is not suitable in animal models. This limitation can be overpassed by chromosomic 242 integration that ensures constitutive expression of the fluorescent reporter without the need for 243 antibiotic pressure [18] . However, the protocol is more labour-intensive and may be difficult to 244 apply to a great number of clinical isolates. We also observed that fluorescence intensity varied 245 from one strain to another. Automatic quantification of bacteria based on fluorescence intensity 246 would require a calibration step for each strain. The ability of some strains to form clump could 247 also have an impact for automated quantification system. Nevertheless, the use of EGFP-248 expressing S. aureus strains may be easier, more specific and more accurate than live labelling 249 of bacteria with fluorescent dyes or cell-permeable nuclear probes [15, 19] . Although only 250 EGFP was tested in this study, the pBSU101 plasmid gives opportunity to replace the egfp gene 251 by another gene coding for other fluorescent proteins such as yellow fluorescent protein or 252 mCherry that have been found suitable to label different S. aureus laboratory strains (RN 4220, 253 SH1000 and SH1001) [20, 21] . 254
To the best of our knowledge, this is the first report describing a large collection of EGFP-255 expressing clinical strains of S. aureus that could represent a useful tool for studying adhesion 256 and internalization within NPPCs such as keratinocytes. This one-step protocol could be further 257 used to develop similar valuable tools aimed to study lifestyle of S. aureus during intracellular 258 persistence or biofilm formation. 
